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A Rapid Attenuation of Muscarinic Agonist Stimulated 
Phosphoinositide Hydrolysis Precedes Receptor 
Sequestration in Human SH-SY-5Y Neuroblastoma Cells* 
Stephen K. Fisher ,  1,2,3 Diana M.  Slowiejko,  1,2 and Edward  L. M c E w e n  I 
(Accepted July 28, 1993) 
Agonist occupancy of muscarinic cholinergic receptors in human SH-SY-5Y neuroblastoma cells 
elicited two kinetically distinct phases of phosphoinositide hydrolysis when monitored by either 
an increased mass of inositol 1,4,5-trisphosphate, or the accumulation of a total inositol phosphate 
fraction. Within 5s of the addition of the muscarinic agonist, oxotremorine-M, the phosphoinositide 
pool was hydrolyzed at a maximal rate of 9.5%/min. This initial phase of phosphoinositide hy- 
drolysis was short-lived (t~/z = 14s) and after 60s of agonist exposure, the rate of inositol lipid 
breakdown had declined to a steady state level of 3.4%/min which was then maintained for at least 
5-10 min. This rapid, but partial, attenuation of muscarinic receptor stimulated phosphoinositide 
hydrolysis occurred prior to the agonist-induced internalization of muscarinic receptors. 
KEY WORDS: Muscarinic cholinergic receptor; phosphoinositide hydrolysis; inositol 1,4,5-trisphosphate; 
SH-SY-5Y neuroblastoma; desensitization. 
INTRODUCTION 
Relatively little is known of the molecular mecha- 
nisms that underlie the regulation of inositol lipid turn- 
over in the central nervous system despite the fact that 
more pharmacologically distinct receptors operate via 
phosphoinositide (PPI) hydrolysis than through any other 
known signal transduction mechanism. Our recent stud- 
ies of the regulation of PPI turnover have utilized two 
human neuroblastoma cell lines (SK-N-SH and its neu- 
roblast subclone, SH-SY-5Y), both of which possess PPI- 
linked muscarinic cholinergic receptors (mAChRs) at 
densities comparable to those found in the central ner- 
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vous system. In these cells (1,2) and in other neural 
tissues (3-6), mAChR-stimulated PPI turnover, as mon- 
itored by a release of radiolabeled inositol phosphates, 
appears not to readily desensitize, i.e., it proceeds con- 
tinuously for an extended time period (30-60 min). The 
eventual loss of functional response is triggered by an 
agonist-induced sequestration and down-regulation of cell 
surface mAChRs (1,7). 
To evaluate further the apparent refractoriness of 
mAChR-stimulated PPI hydrolysis to desensitization, in 
the present study we have examined the rapid kinetics 
of PPI hydrolysis in SH-SY-5Y neuroblastoma, a cell- 
line which possesses a relatively homogeneous popula- 
tion of mAChRs of the m3 subtype (2,8,9). We report 
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here that activation of mAChRs on these cells elicits two 
kineticalIy distinct phases of PPI hydrolysis. A rapid 
initial phase of mAChR-stimulated inositol lipid break- 
down, which was previously unrecognized, occurs dur- 
ing the first few seconds of agonist exposure and results 
in the hydrolysis of the inositol lipid pool at a maximal 
rate of 9.5%/min. This initial component of stimulated 
PPI hydrolysis is followed by a slower but more sus- 
tained phase of inositol lipid breakdown which proceeds 
at a rate of approximately 3.4%/min. The rapid, but 
partial, attenuation of PPI hydrolysis in response to 
mAChR activation occurs prior to mAChR internaliza- 
tion and may represent an important early adaptive re- 
sponse to chronic agonist stimulation. 
EXPERIMENTAL PROCEDURE 
Materials. SH-SY-5Y neuroblastoma cells were obtained from 
Dr. June Biedler, Sloan Kettering Institute, New York. The source of 
SK-N-SH cells was as previously described (10). myo-[2-3H]InositoI 
(15 Ci/mmol) was obtained from American Radiolabeled Chemicals, 
St. Louis, MO. N-pH]Methylscopolamine (pH]NMS: 79.5 Ci/mmoI), 
[3H]qufnuclidinyl benzitate (QNB: 45.4 Ci/mmol) and [3H]oxotremorine- 
M ([3H]Oxo-M: 87.5 Ci/mmol) were from New England Nuclear, 
Boston, MA. Oxotremorine-M was purchased from Research Bio- 
chemicals, Inc., Natick, MA. Atropine was obtained from Sigma 
Chemical Co., St. Louis, MO. Tissue culture supplies were obtained 
from Coming Glass Works, Corning, NY. Powdered Dulbecco's mod- 
ified Eagle's medium and fetal bovine serum were purchased from 
GIBCO, Grand Island, NY. Dowex-1 (100-200 mesh, x 8 in the 
formate form) was obtained from Bio-Rad Laboratories, Melville, NY. 
Cell Culture Conditions. Human SH-SY-5Y (passages 67-94) or 
SK-N-SH ceils (passage number unknown) were grown in tissue cul- 
ture flasks (75 cruZ/250 rot) in 20 mls of Dulbecco's modified Eagle's 
medium supplemented with 10% (by volume) fetal calf serum (Me- 
dium I). Cells were grown for 10-20 days at 37" in an atmosphere 
consisting of 10% COa and 90% humidified air. Cells were detached 
by aspirating Medium I and isolating the cells after incubation with a 
modified Pucks DI solution (10). 
Measurement of Phosphoinositide Turnover. InositoI 1,4,5-tris- 
phosphate [I(1,4,5)P3] mass was measured by a commercially avail- 
able radioreceptor  binding assay kit (Dupont-NEN) ( i1) .  For 
radiolabeling studies, SH-SY-5Y or SK-N-SH cells were allowed to 
prelabel for 3 days in Dulbecco's modified Eagle's medium/10% fetal 
calf serum containing 10 p.Ci/mI [3H]inositol. Isotopic equilibrium 
labeling of inositol lipids in both cell lines was attained within a 48- 
h labeling period. Cells were detached and washed once in Buffer A 
(142 mM NaCt, 5.6 mM KCI, 2.2 mM CaClz, 3.6 mM NaHCO3, 1 
mM MgCI2, 5.6 mM D-glucose, 30 mM sodium HEPES buffer, pH 
7.4). Cells were then resuspended in buffer A containing LiCI (final 
concentration, 20 mM) and preincubated for 2 min at 37~ prior to 
the addition of either 1 mM Oxo-M and/or 50 txM atropine (final 
volume, 0.5 ml). Both the accumulation of [3H]inositol phosphates 
(IP) in the presence of Li +, and incorporation of radiolabel into a total 
inositol lipid fraction (IPL) at time zero, were monitored as previously 
described (1). Radiolabeled phospholipids [phosphatidylinositol 4,5- 
bisphosphate (PIP2); phosphatidylinositol 4-phosphate (PIP) and phos- 
phatidylinositoI (PI)] were extracted from the trichIoroacetic acid pre- 
cipitates, separated by thin layer chromatography and quantitated as 
previously described (12). Rates of PPI hydrolysis were calculated as 
(AIP/IPL) • 100%, where AIP = [3H]IP released/rain at specified 
time points. Protein was determined by the method of Geiger and 
Bessman (13). Students t tests were used to evaluate the statistical 
differences of the means of paired or unpaired sets of data. The curves 
for the rate of [3H]IP accumulation and breakdown of [3H]PIP2 were 
fitted by a non-linear least squares regression analysis assuming an 
exponential decay (GraphPad InPlot). The t~/2 values quoted reflect 
the time required for half-maximal reduction in the initial rate of stim- 
ulated pH]IP formation (Fig. 2B) or half-maximal breakdown of ra- 
diolabeled PIPz initially present (Fig. 3). 
Radioligand Binding. SH-SY-5Y cells were incubated for the times 
indicated in the absence or presence of 1 mM Oxo-M at 37~ (final 
vol = 5 ml). Reactions were terminated by the addition of 30 ml ice- 
cold Buffer A, cells centrifuged at 300 g for 3 min and resuspended 
in Buffer A. Parallel experiments conducted in the presence of 1 txCi 
of [3H]Oxo-M indicated that > 99% of the agonist was removed by 
this procedure. The binding of [3H]NMS or [aH]QNB to mAChRs on 
intact SH-SY-5Y cells was then measured as previously described for 
SK-N-SH cells (14). Cells were incubated overnight with [3H]NMS at 
4~ or for 90 min at 37~ for [3H]QNB binding. 
RESULTS 
I(1, 4, 5)P~ Mass Measurements. The addition of 1 
mM Oxo-M to SH-SY-5Y cells resulted in a rapid, but 
transient, 4-5 fold increase in the mass of I(1,4,5)P3 
within 5-10s. By 60s the net accumulation of I(1,4,5)P3 
had declined to approximately 35% of that attained dur- 
ing the first few seconds of agonist addition. Thereafter, 
the amount of I(1,4,5)P3 remained constant for up to 5 
min of agonist exposure (Fig. 1). 
Accumulation of a Total Inositol Phosphate Frac- 
tion. Because the rapid decline in I(1,4,5)P 3 mass could 
reflect a diminished rate of synthesis or an increased 
metabolism, we also monitored PPI hydrolysis by means 
of the accumulation of a total inositol phosphate fraction 
(IP) in the presence of Li + (1). Under these conditions, 
the addition of 1 mM Oxo-M to SH-SY-5Y cells that 
had been prelabeled to isotopic equilibrium with 
[3H]inositol resulted in a rapid release of [3H]IP, the 
time-course of which was curvilinear over the initial 60s 
following agonist addition (Fig. 2A). However after this 
time, Oxo-M-stimulated [3H]IP formation proceeded Iin- 
early for the next 9 rain (Fig. 2A-inset). When atropine 
(50 ~M) was added to ceils that had been incubated in 
the presence of Oxo-M for 3 rain, the subsequent [3H]IP 
formation was blocked, but accumulated radiolabel did 
not decline over the next 30 rain indicating that Li § fully 
inhibited the degradation of [3H]IP in these cells (data 
not shown). In a series of experiments, [3H]IP formation 
was monitored as a function of time and results ex- 
Rapid Attenuation of mAChR-Stimulated Phosphoinositide Hydrolysis 551 
100 
9 80 





I I I I 
0 1 2 5 
T i m e  ( m i n u t e s )  
Fig. 1. Kinetics of mAChR-stimulated I(1,4,5)P 3 formation. Cells (ap- 
proximately 1 mg of protein) were incubated in the presence of 1 mM 
Oxo-M (o) or buffer A (o) for the times indicated. LiC1 (20 raM) was 
routinely included to allow a direct comparison with [3H]IP data. Val- 
ues shown are means • SEM for four separate experiments. Although 
interexperimental variation was observed in terms of the absolute in- 
crease in the mass of I(1,4,5)P3 formed in the presence of Oxo-M, the 
kinetic profile shown was consistently obtained. Where error bars are 
not shown, the SEM fell within the symbol. *Different from values 
obtained at 60s, p < 0.05. **Different from values obtained with 
buffer A, p < 0.05 (matched-pair analysis). 
pressed relative to radioactivity present in the inositoI 
lipid fraction. From the rate of [3H]IP formation obtained 
after 5s of agonist addition, a PPI breakdown rate of 
9.5%/min was calculated. After 60s of agonist addition, 
the rate of stimulated PPI hydrolysis had declined to 
3.4%/min (h/2 = 14s), and thereafter remained constant 
(Fig. 2B). Under basal conditions (absence of agonist), 
the rate of PPI hydrolysis was 0.06%/rain. Additional 
experiments were also performed with the parent cell 
line, SK-N-SH, which we have previously used for stud- 
ies of mAChR regulation (1,7). As observed for SH-SY- 
5Y cells, the rate of PPI hydrolysis observed after 5s of 
agonist addition was significantly greater than that ob- 
tained after 60s (13.0 _ 4.3 vs 5.0 _+ 1.5%/min, p < 
0.05, n = 4). 
Inositol Lipid Breakdown. The addition of 1 mM 
Oxo-M to SH-SY-5Y cells that had been labeled to iso- 
topic equilibrium with [3H]inositol also resulted in a rapid 
breakdown of [3H]PIP2 (tl/2 = 12s). Sixty seconds after 
agonist addition, however, a new steady state of [3H]PIP2 
label was achieved and maintained for up to 5-10 rain 
(33% of that observed at zero time; Fig. 3). The net loss 
of radiolabel from PIP (33%) and PI (7%) was less marked 
and occurred more slowly than that observed for PIP 2. 
The maintenance of radiolabel in PI following continu- 
ous agonist exposure may reflect its resynthesis and the 
utilization of residual free [3H]inositol present in the cells. 
Because the majority (94%) of label present in the in- 
ositol lipids was recovered in the relatively stable PI 
fraction, radioactivity associated with the total inositol 
lipid fraction was reduced by < 10% during the course 
of the incubations. 
mAChR Sequestration in SH-SY-5Y Cells. To de- 
termine whether the rapid attenuation of PPI hydrolysis 
was related to sequestration of cell surface mAChRs (7), 
the time course of Oxo-M-mediated loss of [3H]NMS 
sites was monitored. No significant loss of [3H]NMS 
sites occurred before 5 rain of exposure of the cells to 
the agonist whereas a maximum sequestration (47 _+ 
2%, n = 3) was observed after 30 rain (Fig. 4). Little 
or no loss of total mAChRs (as revealed by measurement 
of [3H]QNB binding sites) occurred at any of the time 
points examined (8 - 5% at 30 min, n -- 3). 
DISCUSSION 
The principal conclusion to emerge from the present 
study is that two kinetically distinct phases of PPI hy- 
drolysis result from agonist occupancy of mAChRs in 
human SK-N-SH and SH-SY-5Y neuroblastoma cells, 
i.e., an initial rapid phase that, presumably due to its 
transient nature, was not previously identified (1,2) and 
a secondary slower but sustained rate of inositol lipid 
hydrolysis. The biphasic kinetics of mAChR-stimulated 
PPI hydrolysis were evident from measurement of both 
I(1,4,5)P3 mass, and the rate of accumulation of a total 
inositol phosphate fraction. However, the transient na- 
ture of the 4--5 fold increase in I(1,4,5)P 3 mass observed 
within 5-15s of muscarinic agonist addition in this and 
a previous study (11) could reflect either a subsequent 
reduction in the rate of I(1,4,5)P 3 synthesis, or an in- 
creased rate of its metabolism. In this context, previous 
studies with non-neural cells have indicated that agonist- 
stimulated [3H]IP formation can proceed steadily under 
conditions in which little or no net formation of I(1,4,5)P3 
is detected (15,16). In SH-SY-5Y cells, attenuation of 
the rate of mAChR-stimulated PPI hydrolysis was more 
unequivocally demonstrated by the rapid reduction in the 
rate of [3H]IP formation (Fig. 2A,B), since this mea- 
surement is independent of the further metabolism of 
I(1,4,5)P 3 and monitors the continuous accumulation of 
products (1). The rate of Oxo-M-stimulated [3H]IP ac- 
cumulation monitored after 5-15s of agonist exposure 
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Fig. 2. Kinetics of mAChR-stimulated [3H]IP formation. (A): SH-SY-5Y cells labeled to isotopic equilibrium with [aH]inositol (approximately 1 
mg of protein) were incubated with 1 mM Oxo-M for the times indicated. Reactions were terminated by the addition of trichloroacetic acid and a 
total labeled inositol phosphate fraction isolated. Values shown are means _ SEM for triplicate replicates from one of five experiments that gave 
similar results. Inset: stimulated inositol phosphate release in more extended incubations. Little or no increase in basal release of inositol phosphates 
occurred. (B) Rate of mAChR-stimulated PPI hydrolysis (5s-5 min), calculated as (A[3H]IP/IPL) x 100%, where ApH]IP = [3H]IP released/ 
rain at specified time points and IPL is radioactivity present in inositol lipids at time zero. Values shown are means _ SEM for the number of 
separate experiments indicated in parentheses. The basal release of PPI hydrolysis was approximately 0.06%/rain. *Different from the rate measured 
at 60s, p < 0.05. 
consistently exceeded that observed at 60s or thereafter 
by 2-3 fold. The similarities in the kinetics of the ac- 
cumulation of both [aH]IP and I(1,4,5)P3 mass provide 
strong evidence that changes in the rate of mAChR-stim- 
ulated PPI hydrolysis (rather than in the breakdown of 
I(1,4,5)P3) account for the rapid attenuation of enhanced 
inositol lipid turnover in these cells. It should be noted 
that the time period in which the rate of mAChR-stim- 
ulated PPI hydrolysis is highest, i.e., approx. 5-10s after 
agonist addition, is also that time at which the receptor- 
mediated increases in intracellular Ca 2+ (2,11,17) and 
release of inositol lipid-derived diacylglycerols (18) are 
also maximal. 
Although evidence is currently lacking, the reduc- 
tion in m3 mAChR-stimulated PPI hydrolysis in SH-SY- 
5Y cells could conceivably reflect a phosphorylation of 
the m3 receptor (19), as has also been observed for the 
m 2 mAChR linked to adenylyl cyclase activity in heart 
(20). Alternatively, because the rate of PPI hydrolysis 
increases more than 150-fold within 5s of Oxo-M ad- 
dition (0.06 to 9.5%/min, see Fig. 2B), depletion of the 
available PIP2 substrate may account for the subsequent 
reduction in the rate of inositol lipid breakdown. Al- 
though interpretation of changes in [3H]PIP2 is compli- 
cated by the simuitaneous occurrence of both lipid 
degradation and resynthesis, it is noteworthy that the 
tt/2 for Oxo-M-stimulated [3H]PIP2 breakdown (12s) 
closely matched that obtained for the attenuation of the 
rapid phase of [3H]IP formation (14s). PIP2, which is 
formed from the sequential phosphorylation of PI and 
PIP, is the primary substrate for PPI hydrolysis (12). 
However, it comprises only 2-3% of the total inositol 
lipid pool in SH-SY-5Y cells, and thus under conditions 
in which the latter is hydrolyzed at a rate of 9.5%/min, 
the entire PIP2 pool must be renewed every 13-19s. Un- 
der these conditions, the activities of PI- and PIP kinases 
may become rate-limiting and insufficient to replenish 
the PIP2 pool. An additional consideration is that agonist 
sensitive and -insensitive pools of inositol lipid may exist 
(21), in which case the turnover of the relevant pool of 
PIP2 may be even more rapid. In contrast, the resynthesis 
of [3H]PI is maintained even under conditions in which 
inositol reutilization might be comprised, i.e., prolonged 
agonist administration in the presence of Li + (1). Thus, 
inositol availability appears not to be rate-limiting, a 
conclusion consistent with the reportedly high intracel- 
Mar concentrations of inositol (approx. 6 mM) present 
in these neuroblastoma cells (22). Whatever the precise 
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Fig. 3. Kinetics of inositol lipid hydrolysis. Cells labeled to isotopic 
equilibrium with [3H]inositol (approximately 1 mg of protein) were 
incubated with 1 mM Oxo-M for the times indicated. Reactions were 
terminated by the addition of trichloroacetic acid; phospholipids pres- 
ent in the precipitates were then extracted, separated by thin layer 
chromatography and quantitated following autoradiography. Values 
shown are means -+ SEM for 3-4 separate experiments. Little or no 
change in PI, PIP and PIP2 radioactivity occurred under basal condi- 
tions. Of the radioactivity recovered in the inositoI Iipids, 94 _+ 1, 4 
• 1 and 2 • 0% was recovered in PI, PIP and PIP2, respectively. 
Incorporation of [3H]inositoI into the lipid fraction was approximately 
300,000 dpm/mg of protein. 
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Fig. 4. Time-course of mAChR sequestration and down-regulation. 
Cells were incubated in the presence or absence of 1 mM Oxo-M for 
the times indicated. Values shown are means • SEM for 3 separate 
experiments. In control cells, mAChR densities were 298 • 70 and 
319 • 51 fmol/mg protein when monitored by [3H]NMS and [3H]QNB, 
respectively. *Different from corresponding controls, p < 0.05 (matched- 
pair analysis). 
R E F E R E N C E S  
mechan i sm for the at tenuation of PPI hydrolysis ,  it ap- 
pears unrelated to the internal izat ion of mAChRs .  Al-  
though the latter is the precursor of receptor down 
regulat ion and desensit izat ion of  s t imulated PPI hydrol-  
ysis following long-term agonist exposure (1,7), the rapid 
attenuation of PPI hydrolysis  observed in the present 
s tudy occurs prior to, and thus is independent  of, the 
redistr ibution of  cell surface mAChRs .  
In summary ,  the present  results indicate that the rate 
of muscar in ic  agonis t-s t imulated PPI hydrolysis  in SH- 
SY-5Y cells undergoes  a rapid, but  partial,  a t tenuation.  
This change in m A C h R  responsiveness  may  represent  an 
early adaptive phase in PPI-mediated signal t ransduction 
not previous ly  recognized in these cells. 
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